Nath Bio-Genes (India) Limited
NATHBIOGEN.NS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.49B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.49 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $2.00 |
| Dividend yield | 1.53% |
| Earnings per Share | $20.98 |
| Beta | 0.85 |
| Outstanding Shares | 19,004,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 7.11 |
|---|---|
| PEG | -52.8 |
| Price to Sales | 0.54 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Nath Bio-Genes (India) Limited
452 employees
CEO: Satish Kagliwal
Nath Bio-Genes (India) Limited, established in 1979 and headquartered in Aurangabad, India, specializes in the development, processing, and global distribution of both hybrid and genetically modified seeds. The company's operations are d...